[January 30, 2015]

Research and Markets: Latest Sales Figures in the Oncology Drug Pipeline Market 2015

Research and Markets (http://www.researchandmarkets.com/research/6tb4th/the_latest_sales) has announced the addition of the "The Latest Sales Figures in Oncology Drug Pipeline Update 2015" report to their offering.

The Latest Sales Figures in Oncology brings together up to 5 years of sales data on the top 70+ cancer drugs by country/region from both global pharmaceutical companies to progressive biotech companies. The analysis leverages the power of the author's 1stOncology intelligence, which combines company disclosed product sales and detailed drug development information. The result is not only a unique insight into the developmental positioning of each marketed drug but, together, they alo tell us how they will continue to change the competitive landscape and with what force.

There are today 38 companies plus partners developing 79 drugs in 1,014 developmental projects in cancer. In addition, there are 2 suspended drugs, and the accumulated number of ceased drugs over the last years amounts to another 20 drugs. The Latest Sales Figures In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them.

Identified drugs are linked to 86 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date, 83 out of the 85 studied drug targets so far have been recorded with somatic mutations.

The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drug targets are further categorized on in the software application by 27 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

Pipeline Breakdown According to Number of Drugs

• Marketed - 71
• Pre-registration - 4
• Phase III - 45
• Phase II - 64
• Phase I - 47
• Preclinical - 2
• No Data - 3
• Suspended - 2
• Ceased - 20

Delivery Format: Desktop App plus Online Access to Updates (One Year)

For more information visit http://www.researchandmarkets.com/research/6tb4th/the_latest_sales.

[ Back To TMCnet.com's Homepage ]